Notice NOT-CA-24-040 from the NIH Guide for Grants and Contracts

Notice NOT-HD-24-024 from the NIH Guide for Grants and Contracts

Notice NOT-DC-24-028 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-108 from the NIH Guide for Grants and Contracts

Notice NOT-OH-24-011 from the NIH Guide for Grants and Contracts

Notice NOT-AG-24-013 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-036 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-153 from the NIH Guide for Grants and Contracts. The purpose of the Worta McCaskill-Stevens K12 funding opportunity is to support institutional career development awards designed to prepare newly trained clinicians who have made a commitment to independent research careers in community oncology or cancer prevention, and to facilitate their transition to more advanced support mechanisms or independent research funding (e.g., K08, R03, R21, R01). The NOFO will allow the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communities in cancer clinical research, as part of their research and career development.

Funding Opportunity PAR-24-110 from the NIH Guide for Grants and Contracts. The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce health disparities for other health outcomes among populations that experience health disparities.

Notice NOT-GM-24-027 from the NIH Guide for Grants and Contracts

Notice NOT-DC-24-027 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-230 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-103 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-107 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-24-201 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) hereby notify the applicant community that funds may be available for applications based on a presidentially declared disaster under the Stafford Act, a public health emergency declared by the Secretary, HHS, or other local, regional or national disaster. Applications in response to Emergency Notices of Special Interest (NOSIs) will be routed directly to the NIH awarding component signed on to the Emergency NOSI. Only applications submitted in response to an Emergency NOSI published by an IC will be allowed to apply to this NOFO.

Notice NOT-AI-24-042 from the NIH Guide for Grants and Contracts

Notice NOT-DA-24-026 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-197 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) listed in this NOFO. This NOFO is intended to jumpstart research on understudied proteins within the context of pain and pain management and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins to identify new druggable targets for pain. This NOFO is part of the NIH Helping to End Addiction Long Term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.

Funding Opportunity PAR-24-174 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs. Training related to prevention, treatment or public health approaches to any technical area of basic, epidemiology, clinical, behavioral or social science health research may be supported. Research Training programs should incorporate didactic, mentored research and career development skills components to prepare individuals for careers that will have significant impact on the priority health research needs of LMICs. This Funding Opportunity Announcement (FOA) allows support of [trainees] as the lead investigator of an independent clinical trial; or a separate ancillary clinical trial or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Notice NOT-EB-24-007 from the NIH Guide for Grants and Contracts